BioAge Labs, Inc. (BIOA) — Dilution Risk Analysis

Current Snapshot

BioAge Labs, Inc. (BIOA) has a DilutionWatch score of 27/10 and is classified as MEDIUM risk. The score date in the source data is 2026-10-03T03:45:52.527348.

This page is assembled from sourced share-structure, market-data, SEC-filing, and DilutionWatch fields. Missing values are left blank rather than estimated.

Share Structure

Shares Outstanding
45,896,909 Source
Public Float
33,688,504 Source
Float as % of Outstanding
73.4%

Dilution Risk Score

Score: 27/10 Source (as of 2026-10-03T03:45:52.527348)

Recent SEC Filings

Recent filing forms in the source payload: XBRL 1, 4 9.

FormFiledAccession
xbrl 2026-06-30 xbrl-3520-xbrl_warrant
4 2026-04-03 0001210905-26-000011
4 2026-03-03 0001120478-26-000011
4 2026-03-03 0001210905-26-000009
4 2026-02-19 0001836297-26-000002
4 2026-02-19 0002032751-26-000010
4 2026-02-19 0001120478-26-000009
4 2026-02-19 0002036289-26-000002
4 2026-02-19 0001210905-26-000007
4 2026-02-03 0001120478-26-000007

Dilution Risk Drivers

DriverStored ValueSource
ATM offering capacity remaining $114,999,983 Source
Cash runway 46 months Source
Three-year share count growth 32.04% Source

DilutionWatch Analysis

Risk Level
MEDIUM (Score: 27/10) Source
Cash Runway
46 months Source
ATM Offering Capacity Remaining
$114,999,983 Source
Share Count Growth (3-Year)
32.04% Source

What This Page Does Not Estimate

DilutionWatch does not infer missing cash runway, authorized share count, ATM capacity, shelf capacity, or share-growth values on this page. A blank field means the current source payload did not provide a usable value with provenance.

Scores and classifications are shown only when supplied by the DilutionWatch data layer. SEC filing rows link to their source accession when a filing URL is available.